Assessment of Mortality from COVID-19 in a Multicultural Multi-ethnic Patient Population
Overview
Authors
Affiliations
Background: Studies indicate that ethnicity and socioeconomic disparity are significant facilitators for COVID-19 mortality. The United Arab Emirates, distinctly has a population of almost 12% citizens and the rest, immigrants, are mainly unskilled labourers. The disparate socio-economic structure, crowded housing conditions, and multi-ethnic population offer a unique set of challenges in COVID-19 management.
Methods: Patient characteristics, comorbidities, and clinical outcomes data from the electronic patient medical records were retrospectively extracted from the hospital information system of the two designated public COVID-19 referral hospitals. Chi-square test, logistic regression, and odds ratio were used to analyse the variables.
Results: From, the total of 3072 patients, less than one-fifth were females; the Asian population (71.2%);followed by Middle Eastern Arabs (23.3%) were the most infected by the virus. Diabetes Mellitus (26.8%), hypertension (25.7%) and heart disease (9.6%) were the most prevalent comorbidities observed among COVID-19 patients. Kidney disease as comorbidity significantly diminished the survival rates (Crude OR 9.6, 95% CI (5.6-16.6), p < 0.001) and (Adjusted OR 5.7 95% CI (3.0 - 10.8), p < 0.001), as compared to those patients without kidney disease. Similarly, the higher age of patients between 51 and 65 years, significantly decreased the odds for survival (Crude OR 14.1 95% CI (3.4-58.4), p < 0.001) and (Adjusted OR 12.3 95% CI (2.9 - 52.4), p < 0.001). Patient age beyond 66 years, further significantly decreased the odds for survival (Crude OR 36.1 95% CI (8.5-154.1), p < 0.001), and (Adjusted OR 26.6 95% CI (5.7 - 123.8), p < 0.001).
Conclusion: Our study indicates that older ages above 51 years and kidney disease increased mortality significantly in COVID-19 patients. Ethnicity was not significantly associated with mortality in the UAE population. Our findings are important in the management of the COVID-19 disease in the region with similar economic, social, cultural, and ethnic backgrounds.
Hintermeier M, Gottlieb N, Rohleder S, Oppenberg J, Baroudi M, Pernitez-Agan S EClinicalMedicine. 2025; 74:102698.
PMID: 39764176 PMC: 11701484. DOI: 10.1016/j.eclinm.2024.102698.
Lipski D, Radziemski A, Wasiliew S, Wyrwa M, Szczepaniak-Chichel L, Stryczynski L BMC Infect Dis. 2024; 24(1):685.
PMID: 38982355 PMC: 11234702. DOI: 10.1186/s12879-024-09592-7.
Gastrointestinal Bleeding in COVID-19 Infected Patients, and Management Outcomes.
Al Hanaei A, AlKindi F, Alkhemeiri A, Nair S Int J Gen Med. 2024; 17:1145-1153.
PMID: 38559591 PMC: 10981877. DOI: 10.2147/IJGM.S454841.
Alawadi F, Bashier A, Bin Hussain A, Al-Hashmi N, Bachet F, Hassanein M World J Diabetes. 2023; 14(8):1259-1270.
PMID: 37664471 PMC: 10473944. DOI: 10.4239/wjd.v14.i8.1259.
Hammad M, Tashtoush M, El Faki E, Hajaj M, Ahmed S, Darwish A J Pharm Policy Pract. 2023; 16(1):36.
PMID: 36864489 PMC: 9979894. DOI: 10.1186/s40545-023-00542-3.